Cholesterol derivs
I Cpds. of general formula:- (I) where R' = Cl, OH, (1-18C) O-acyl or (1-4C)O-alkyl and R2 = one of the following:- 1. CH(Me)N(Me)CH2CHMe2 2. CH(Me)CH2N(Me)CHMe2 3. CH(Me)N(Me)(CH2)2CHMe2 4. CH(Me)CH2N(Me)CH2CHMe2 5. CH(Me)(CH2)2N(Me)CHMe2 6. CH(Me)(CH2)2NMe2 7. CH(Me)(CH2)2NEtMe 8. CH(Me)O(CH2...
Gespeichert in:
Hauptverfasser: | , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; ger |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | BORK,KARL-HEINZ,DR KRAEMER,JOSEF,DR WATZEL,RUDOLF,DR BRUECKNER,KLAUS,DR IRMSCHER,KLAUS,DR VOEGE,HANS-OTTO,DR |
description | I Cpds. of general formula:- (I) where R' = Cl, OH, (1-18C) O-acyl or (1-4C)O-alkyl and R2 = one of the following:- 1. CH(Me)N(Me)CH2CHMe2 2. CH(Me)CH2N(Me)CHMe2 3. CH(Me)N(Me)(CH2)2CHMe2 4. CH(Me)CH2N(Me)CH2CHMe2 5. CH(Me)(CH2)2N(Me)CHMe2 6. CH(Me)(CH2)2NMe2 7. CH(Me)(CH2)2NEtMe 8. CH(Me)O(CH2)2NMe2 9. O-(CH2)2NEt2 10. -O-(CH2)2 11. -N(Me)(CH2)2CHMe2 12. -N(Me)(CH2)2NHCHMe2 13. -N(Me)(CH2)2N(Et)CHMe2 14. CH(Me)N(Me)CH2CHEt2 15. CH(Me)N(Et)CH2CHEt2 16. CH(Me)CH2N(Me)CHEt2 17. CH(Me)CH2N(Et)CHEt2 18. -O-(CH2)2NMeEt 19. N(Me)(CH2)2CHMeEt 20. CH(Me)N(Et)CH2CHMe2 21. CH(Me)CH2N(Et)CHMe2 22. CH(Me)N(Et)(CH2)2CHMe2 23. CH(Me)CH2N(Et)CH2CHMe2 24. CH(Me)(CH2)2N(Et)CHMe2 25. CH(Me)(CH2)3NMe2 26. CH(Me)(CH2)2NEt2 27. -O-(CH2)2NMe2 28. -O-(CH2)2 29. -O-(CH2)3NMe2 30. -N(Me)(CH2)3CHMe2 31. -N(Me)(CH2)2N(Me)CHMe2 32. -N(Me)(CH2)2-O-CHMe2 33. CH(Me)N(Me)CH2CHMeEt 34. CH(Me)N(Et)CH2CHMeEt 35. CH(Me)CH2N(Me)CHMeEt 36. CH(Me)CH2N(Et)CHMeEt 37. N(Me)(CH2)2CHEt2 II Acid addn. salts and pharm. prepns. of I. Hypocholesteremics, blocking cholesterol synthesis. Dose 2-300 mg. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CH524591A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CH524591A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CH524591A3</originalsourceid><addsrcrecordid>eNrjZBByzsjPSS0uSS3Kz1FISS3KLCvmYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxzh6mRiamloaOxgQVAABVTR7s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Cholesterol derivs</title><source>esp@cenet</source><creator>BORK,KARL-HEINZ,DR ; KRAEMER,JOSEF,DR ; WATZEL,RUDOLF,DR ; BRUECKNER,KLAUS,DR ; IRMSCHER,KLAUS,DR ; VOEGE,HANS-OTTO,DR</creator><creatorcontrib>BORK,KARL-HEINZ,DR ; KRAEMER,JOSEF,DR ; WATZEL,RUDOLF,DR ; BRUECKNER,KLAUS,DR ; IRMSCHER,KLAUS,DR ; VOEGE,HANS-OTTO,DR</creatorcontrib><description>I Cpds. of general formula:- (I) where R' = Cl, OH, (1-18C) O-acyl or (1-4C)O-alkyl and R2 = one of the following:- 1. CH(Me)N(Me)CH2CHMe2 2. CH(Me)CH2N(Me)CHMe2 3. CH(Me)N(Me)(CH2)2CHMe2 4. CH(Me)CH2N(Me)CH2CHMe2 5. CH(Me)(CH2)2N(Me)CHMe2 6. CH(Me)(CH2)2NMe2 7. CH(Me)(CH2)2NEtMe 8. CH(Me)O(CH2)2NMe2 9. O-(CH2)2NEt2 10. -O-(CH2)2 11. -N(Me)(CH2)2CHMe2 12. -N(Me)(CH2)2NHCHMe2 13. -N(Me)(CH2)2N(Et)CHMe2 14. CH(Me)N(Me)CH2CHEt2 15. CH(Me)N(Et)CH2CHEt2 16. CH(Me)CH2N(Me)CHEt2 17. CH(Me)CH2N(Et)CHEt2 18. -O-(CH2)2NMeEt 19. N(Me)(CH2)2CHMeEt 20. CH(Me)N(Et)CH2CHMe2 21. CH(Me)CH2N(Et)CHMe2 22. CH(Me)N(Et)(CH2)2CHMe2 23. CH(Me)CH2N(Et)CH2CHMe2 24. CH(Me)(CH2)2N(Et)CHMe2 25. CH(Me)(CH2)3NMe2 26. CH(Me)(CH2)2NEt2 27. -O-(CH2)2NMe2 28. -O-(CH2)2 29. -O-(CH2)3NMe2 30. -N(Me)(CH2)3CHMe2 31. -N(Me)(CH2)2N(Me)CHMe2 32. -N(Me)(CH2)2-O-CHMe2 33. CH(Me)N(Me)CH2CHMeEt 34. CH(Me)N(Et)CH2CHMeEt 35. CH(Me)CH2N(Me)CHMeEt 36. CH(Me)CH2N(Et)CHMeEt 37. N(Me)(CH2)2CHEt2 II Acid addn. salts and pharm. prepns. of I. Hypocholesteremics, blocking cholesterol synthesis. Dose 2-300 mg.</description><edition>1</edition><language>eng ; ger</language><subject>CHEMISTRY ; METALLURGY ; ORGANIC CHEMISTRY ; STEROIDS</subject><creationdate>1972</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19720630&DB=EPODOC&CC=CH&NR=524591A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25551,76302</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19720630&DB=EPODOC&CC=CH&NR=524591A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BORK,KARL-HEINZ,DR</creatorcontrib><creatorcontrib>KRAEMER,JOSEF,DR</creatorcontrib><creatorcontrib>WATZEL,RUDOLF,DR</creatorcontrib><creatorcontrib>BRUECKNER,KLAUS,DR</creatorcontrib><creatorcontrib>IRMSCHER,KLAUS,DR</creatorcontrib><creatorcontrib>VOEGE,HANS-OTTO,DR</creatorcontrib><title>Cholesterol derivs</title><description>I Cpds. of general formula:- (I) where R' = Cl, OH, (1-18C) O-acyl or (1-4C)O-alkyl and R2 = one of the following:- 1. CH(Me)N(Me)CH2CHMe2 2. CH(Me)CH2N(Me)CHMe2 3. CH(Me)N(Me)(CH2)2CHMe2 4. CH(Me)CH2N(Me)CH2CHMe2 5. CH(Me)(CH2)2N(Me)CHMe2 6. CH(Me)(CH2)2NMe2 7. CH(Me)(CH2)2NEtMe 8. CH(Me)O(CH2)2NMe2 9. O-(CH2)2NEt2 10. -O-(CH2)2 11. -N(Me)(CH2)2CHMe2 12. -N(Me)(CH2)2NHCHMe2 13. -N(Me)(CH2)2N(Et)CHMe2 14. CH(Me)N(Me)CH2CHEt2 15. CH(Me)N(Et)CH2CHEt2 16. CH(Me)CH2N(Me)CHEt2 17. CH(Me)CH2N(Et)CHEt2 18. -O-(CH2)2NMeEt 19. N(Me)(CH2)2CHMeEt 20. CH(Me)N(Et)CH2CHMe2 21. CH(Me)CH2N(Et)CHMe2 22. CH(Me)N(Et)(CH2)2CHMe2 23. CH(Me)CH2N(Et)CH2CHMe2 24. CH(Me)(CH2)2N(Et)CHMe2 25. CH(Me)(CH2)3NMe2 26. CH(Me)(CH2)2NEt2 27. -O-(CH2)2NMe2 28. -O-(CH2)2 29. -O-(CH2)3NMe2 30. -N(Me)(CH2)3CHMe2 31. -N(Me)(CH2)2N(Me)CHMe2 32. -N(Me)(CH2)2-O-CHMe2 33. CH(Me)N(Me)CH2CHMeEt 34. CH(Me)N(Et)CH2CHMeEt 35. CH(Me)CH2N(Me)CHMeEt 36. CH(Me)CH2N(Et)CHMeEt 37. N(Me)(CH2)2CHEt2 II Acid addn. salts and pharm. prepns. of I. Hypocholesteremics, blocking cholesterol synthesis. Dose 2-300 mg.</description><subject>CHEMISTRY</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>STEROIDS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1972</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBByzsjPSS0uSS3Kz1FISS3KLCvmYWBNS8wpTuWF0twMcm6uIc4euqkF-fGpxQWJyal5qSXxzh6mRiamloaOxgQVAABVTR7s</recordid><startdate>19720630</startdate><enddate>19720630</enddate><creator>BORK,KARL-HEINZ,DR</creator><creator>KRAEMER,JOSEF,DR</creator><creator>WATZEL,RUDOLF,DR</creator><creator>BRUECKNER,KLAUS,DR</creator><creator>IRMSCHER,KLAUS,DR</creator><creator>VOEGE,HANS-OTTO,DR</creator><scope>EVB</scope></search><sort><creationdate>19720630</creationdate><title>Cholesterol derivs</title><author>BORK,KARL-HEINZ,DR ; KRAEMER,JOSEF,DR ; WATZEL,RUDOLF,DR ; BRUECKNER,KLAUS,DR ; IRMSCHER,KLAUS,DR ; VOEGE,HANS-OTTO,DR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CH524591A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; ger</language><creationdate>1972</creationdate><topic>CHEMISTRY</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>STEROIDS</topic><toplevel>online_resources</toplevel><creatorcontrib>BORK,KARL-HEINZ,DR</creatorcontrib><creatorcontrib>KRAEMER,JOSEF,DR</creatorcontrib><creatorcontrib>WATZEL,RUDOLF,DR</creatorcontrib><creatorcontrib>BRUECKNER,KLAUS,DR</creatorcontrib><creatorcontrib>IRMSCHER,KLAUS,DR</creatorcontrib><creatorcontrib>VOEGE,HANS-OTTO,DR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BORK,KARL-HEINZ,DR</au><au>KRAEMER,JOSEF,DR</au><au>WATZEL,RUDOLF,DR</au><au>BRUECKNER,KLAUS,DR</au><au>IRMSCHER,KLAUS,DR</au><au>VOEGE,HANS-OTTO,DR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Cholesterol derivs</title><date>1972-06-30</date><risdate>1972</risdate><abstract>I Cpds. of general formula:- (I) where R' = Cl, OH, (1-18C) O-acyl or (1-4C)O-alkyl and R2 = one of the following:- 1. CH(Me)N(Me)CH2CHMe2 2. CH(Me)CH2N(Me)CHMe2 3. CH(Me)N(Me)(CH2)2CHMe2 4. CH(Me)CH2N(Me)CH2CHMe2 5. CH(Me)(CH2)2N(Me)CHMe2 6. CH(Me)(CH2)2NMe2 7. CH(Me)(CH2)2NEtMe 8. CH(Me)O(CH2)2NMe2 9. O-(CH2)2NEt2 10. -O-(CH2)2 11. -N(Me)(CH2)2CHMe2 12. -N(Me)(CH2)2NHCHMe2 13. -N(Me)(CH2)2N(Et)CHMe2 14. CH(Me)N(Me)CH2CHEt2 15. CH(Me)N(Et)CH2CHEt2 16. CH(Me)CH2N(Me)CHEt2 17. CH(Me)CH2N(Et)CHEt2 18. -O-(CH2)2NMeEt 19. N(Me)(CH2)2CHMeEt 20. CH(Me)N(Et)CH2CHMe2 21. CH(Me)CH2N(Et)CHMe2 22. CH(Me)N(Et)(CH2)2CHMe2 23. CH(Me)CH2N(Et)CH2CHMe2 24. CH(Me)(CH2)2N(Et)CHMe2 25. CH(Me)(CH2)3NMe2 26. CH(Me)(CH2)2NEt2 27. -O-(CH2)2NMe2 28. -O-(CH2)2 29. -O-(CH2)3NMe2 30. -N(Me)(CH2)3CHMe2 31. -N(Me)(CH2)2N(Me)CHMe2 32. -N(Me)(CH2)2-O-CHMe2 33. CH(Me)N(Me)CH2CHMeEt 34. CH(Me)N(Et)CH2CHMeEt 35. CH(Me)CH2N(Me)CHMeEt 36. CH(Me)CH2N(Et)CHMeEt 37. N(Me)(CH2)2CHEt2 II Acid addn. salts and pharm. prepns. of I. Hypocholesteremics, blocking cholesterol synthesis. Dose 2-300 mg.</abstract><edition>1</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; ger |
recordid | cdi_epo_espacenet_CH524591A |
source | esp@cenet |
subjects | CHEMISTRY METALLURGY ORGANIC CHEMISTRY STEROIDS |
title | Cholesterol derivs |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T21%3A03%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BORK,KARL-HEINZ,DR&rft.date=1972-06-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECH524591A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |